We are live on
!
Find out more
BTW
Boston Trust Walden Portfolio holdings
AUM
$13.1B
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.19%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.19B
AUM Growth
–
Cap. Flow
+$6.13B
Cap. Flow
% of AUM
99.03%
Top 10 Holdings %
Top 10 Hldgs %
11.07%
Holding
316
New
316
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$79.1M |
| 2 |
W.W. Grainger
GWW
|
+$78.4M |
| 3 |
T. Rowe Price
TROW
|
+$77.5M |
| 4 |
Donaldson
DCI
|
+$68.3M |
| 5 |
Accenture
ACN
|
+$63.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.05% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 14.45% |
| 4 | Consumer Discretionary | 12.92% |
| 5 | Healthcare | 12.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
VF Corp
VFC
$5B
| $396K | 0.01% |
+8,708
| New | +$370K |
|
277
Caterpillar
CAT
$360B
| $388K | 0.01% |
+4,708
| New | +$400K |
|
|
EPAY
278
DELISTED
Bottomline Technologies Inc
EPAY
| $384K | 0.01% |
+15,150
| New | +$404K |
|
279
Rockwell Automation
ROK
$46.3B
| $374K | 0.01% |
+4,500
| New | +$389K |
|
|
DD
280
DELISTED
Du Pont De Nemours E I
DD
| $369K | 0.01% |
+7,410
| New | +$374K |
|
281
Southern Company
SO
$98.9B
| $366K | 0.01% |
+8,300
| New | +$382K |
|
282
Murphy Oil
MUR
$5.79B
| $349K | 0.01% |
+6,630
| New | +$359K |
|
283
Edgewell Personal Care
EPC
$1.23B
| $335K | 0.01% |
+4,498
| New | +$327K |
|
284
Vanguard Real Estate ETF
VNQ
$37.2B
| $321K | 0.01% |
+4,675
| New | +$340K |
|
285
Ingredion
INGR
$6.25B
| $318K | 0.01% |
+4,840
| New | +$340K |
|
|
PDCO
286
DELISTED
Patterson Companies, Inc.
PDCO
| $318K | 0.01% |
+8,450
| New | +$322K |
|
287
Novartis
NVS
$263B
| $314K | 0.01% |
+4,957
| New | +$323K |
|
288
Moody's
MCO
$80.9B
| $313K | 0.01% |
+5,130
| New | +$311K |
|
289
Honeywell
HON
$64.5B
| $312K | 0.01% |
+4,378
| New | +$302K |
|
290
Thermo Fisher Scientific
TMO
$237B
| $307K | 0.01% |
+3,625
| New | +$302K |
|
291
Norfolk Southern
NSC
$71.9B
| $303K | ﹤0.01% |
+4,175
| New | +$319K |
|
292
Idexx Laboratories
IDXX
$40.2B
| $287K | ﹤0.01% |
+6,400
| New | +$280K |
|
293
Amgen
AMGN
$203B
| $286K | ﹤0.01% |
+2,900
| New | +$301K |
|
294
Eaton
ETN
$152B
| $284K | ﹤0.01% |
+4,314
| New | +$272K |
|
295
NextEra Energy
NEE
$169B
| $277K | ﹤0.01% |
+13,600
| New | +$270K |
|
296
Parker-Hannifin
PH
$117B
| $265K | ﹤0.01% |
+2,775
| New | +$260K |
|
|
MRSH
297
Marsh
MRSH
$85.8B
| $263K | ﹤0.01% |
+6,600
| New | +$258K |
|
298
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
| $251K | ﹤0.01% |
+6,400
| New | +$249K |
|
299
Henry Schein
HSIC
$9.75B
| $249K | ﹤0.01% |
+6,630
| New | +$243K |
|
|
UN
300
DELISTED
Unilever NV New York Registry Shares
UN
| $246K | ﹤0.01% |
+6,265
| New | +$258K |
|
Similar funds
MG
GLA
VLKIM
BCI
EIG
PCM
WHG
CRM
Boston Trust Walden's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Trust Walden, which disclosed 316 positions worth $6.19B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is ExxonMobil: 878,708 shares worth $79.4M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, followed by Technology and Industrials.
- Boston Trust Walden's largest Q2 2013 buy was ExxonMobil: 878,708 shares worth $79.4M.
- Boston Trust Walden's ten largest holdings make up 11% of its $6.19B portfolio in Q2 2013.
- Boston Trust Walden disclosed 316 positions in Q2 2013, its first 13F filing on record.
Based on Boston Trust Walden's 13F filing for Q2 2013, filed 8 Aug 2013.